People with severe psoriasis are at an increased risk of developing serious medical conditions, including cardiovascular disease and diabetes, says a dermatologist from the University of Pennsylvania.

One in three people with Type 2 diabetes are given medication too soon, instead of being urged to eat better and do more exercise, a UK study suggests.

The FDA will take longer to review Alogliptin, an experimental diabetes pill developed by Takeda, delaying a potential blockbuster billion-dollar seller from reaching the market.

Surge in anxiety-linked hormone worsens blood sugar level, researchers suggest and stress may play a key role in the development of Type 2 diabetes in obese black women, U.S. researchers say.

Drugs blocking this communication may offer therapeutic benefits, study finds.

A new study may help explain why diets high in the sugar fructose have been linked to insulin resistance, a precursor to Type 2 diabetes.

“Power to Prevent: A Family Lifestyle Approach to Diabetes” helps African Americans learn how to prevent or delay Type 2 diabetes through physical activity and making healthy food choices.

Abnormal glucose tolerance can be detected by a carbon-13 labeled oral glucose tolerance test in which 13-CO2 excreted in the breath is measured with a standard breath analyzer, according to research conducted at the University of Texas Medical Branch in Galveston.

Duloxetine, pregabalin, and gabapentin offer similar efficacy for patients with diabetic peripheral neuropathic pain, according to a new report. 

Treating diabetic survivors of acute myocardial infarction (AMI) with prandial vs. basal insulin strategies resulted in similar levels of hemoglobin A1c and no difference in the risk for cardiovascular events, according to the results of a multinational, randomized HEART2D controlled trial.